New Identity® Shoulder System and Comprehensive® Reverse Systems Offer Smaller Components and Tools Developed with Smaller Patient Anatomy in Mind (Warsaw, Ind.) April 17, 2026 — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a line extension to the existing Identity® Shoulder System and Comprehensive® Rever
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.